Immunogenicity and Safety Trial of Quadrivalent Influenza Vaccine Administered by Intradermal Route in Adult Subjects Aged 18 through 64 Years

Project Details

StatusFinished
Effective start/end date12/10/1231/10/15

Funding

  • Sanofi Pasteur, Inc.: $163,625.00

Keywords

  • Biotechnology & Drug Development, Infectious Diseases